LACTEL® Polymers

Discover Evonik’s portfolio of LACTEL® Polymers. These versatile, PLGA-based copolymers are formulated in a range of inherent viscosities and degradation rates for optimized formulation. With a range of 15 available polymers, these are cost-effective products for controlled drug release in the pharmaceutical industry. Specifically designed to meet the diverse needs of pharmaceutical applications, LACTEL® Polymers offer predictable and reliable performance across various medical and therapeutic domains. Their range of viscosities and degradation times ensures tailored release profiles for drugs, enhancing both efficacy and patient compliance. Additionally, LACTEL® Polymers are known for their high purity and consistent quality, making them a trusted choice for formulators looking to develop innovative drug delivery systems. Evonik remains committed to providing advanced polymer solutions that improve drug stability and release, underlining their leadership in the drug development sector.

Controlled drug release: LACTEL® polymers can be used to create drug delivery systems that release medication at a controlled rate, reducing the need for frequent dosing and improving patient compliance.
Biocompatibility: LACTEL® polymers are made from glycolic acid and lactic acid, which are naturally occurring compounds in the body, making them biocompatible and reducing the risk of adverse reactions.
Parenteral drug delivery: LACTEL® polymers can be used to create injectable drug delivery systems, providing a convenient and pain-free alternative to oral medication.
Customizable degradation rates: LACTEL® polymers can be formulated to degrade at varying rates, allowing for tailored drug release profiles.